Clinical Impact of Pharmacist Counseling on Type 2 Diabetes Patiens
Article Sidebar
Main Article Content
Abstract
Introduction: To evaluate the impact of pharmacist counseling on glycemic control, knowledge and adherence in patients with type 2 diabetes mellitus. Materials and Method: A randomized controlled trial was performed in type 2 diabetic patients treated with oral anti-hyperglycemic agents and Glycosylated Hemoglobin (HbA1C) levels greater than 7% at Trat Hospital from May 2012 to February 2013. A total of 158 patients were selected and randomly allocated into control group (n = 78) and study group (n = 80). The study group received educational interventions from a pharmacist about diabetes mellitus, complications, use of oral anti-hyperglycemic medications, adverse drug reaction, diet, exercise and other self-care by documentation explaining when patient followed up every 12-16 weeks. Control group received usual care only. The descriptive statistics and independent samples t-test were used in the analysis of data. Results: After pharmacist interventions, HbA1c level in the study group decreased significantly compared to control group (HbA1c = 7.64 + 1.35 vs 8.45 + 1.41; P < 0.01). After education, LDL-C were lower than those at baseline (after education, LDL-C = 86.76 + 30.86 and at baseline, LDL-C = 103.64 + 33.88) but not significantly different from control group. (LDL-C = 86.76 + 30.86 vs 95.01 + 37.31; P = 0.14). The diabetic knowledge scores and percent pill count were increased significantly compared to control group (diabetic knowledge scores = 19.90 + 1.23 vs 16.38 + 2.65; P < 0.01, percent pill count = 94.43 + 6.94 vs 89.72 + 11.96; P = 0.01). Conclusion: The pharmacist counseling in diabetic patients improved glycemic control, knowledge and medication adherence.
Article Details
In the case that some parts are used by others The author must Confirm that obtaining permission to use some of the original authors. And must attach evidence That the permission has been included
References
Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL and Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care 2005; 11(4): 253-260.
Clifford RM, Davis WA, Batty KT and Davis TME. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes. Diabetes Care 2005; 28(4): 771-776.
Farsaei S, Sabzghabaee AM, Zargarzadeh AH and Amini M. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci 2011; 16(1): 43-49.
International Diabetes Federation. Diabetes [online]. 2013 Nov 13 [cited 2013 Nov 16]. Available from: www.diabassocthai.org/news_and_knowledge/221
Jameson JP and Baty PJ. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am J Manag Care 2010; 16(4): 250-255.
Jarab AS, Alqudah SG, Mukattash TL, Shattat G and Qirim TA. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm 2012; 18(7): 516-526.
Lee VWY and Leung PY. Glycemic control and medication compliance in diabetic patients in a pharmacist-managed clinic in Hong Kong. Am J Health-Syst Pharm 2003; 60: 2593-2596.
Malathy R, Narmadha MP, Ramesh S, Alvin JM and Dinesh BN. Effect of a diabetes counseling programme on knowledge, attitude and practice among diabetic patients in Erode district of South India. J Young Pharm 2011; 3(1): 65-72.
McPherson ML, Smith SW, Powers A and Zuckerman IH. Association between diabetes patients knowledge about medications and their blood glucose control. Res Social Adm Pharm 2008; 4(1): 37-45.
Norris SL, Lau J, Smith SJ, Schmid CH and Engelgau MM. Self-management education for adults with type 2 diabetes. A meta-analysis of the effect on glycemic control. Diabetes Care 2002; 25: 1159-1171.
Phumipamorn S, Pongwecharak J, Soorapan S and Pattharachayakul S. Effects of the pharmacist’s input on glycaemic control and cardiovascular risks in Muslim diabetes. Primary care diabetes 2008; 25: 31-37.
Rothman RL, Malone R, Bryant B, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005; 118: 276-284.
Teanchairoj A. Determination of risk factors and prevalence of vascular complications among Thai diabetic patients in five government hospital. Thesis; Master of Science in Pharmacy, Mahidol university Bangkok 2005.
Wild S, Roglic G, Green A, Sicree R and King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5): 1047-1053.
Wongwiwatthananukit S, Krittiyanunt S and Wannapinyo A. Development and validation of an instrument to assess the general knowledge of patients with diabetes. Thai J Pharm Sci 2004; 28(1-2): 17-29.